Physician: Ozempic patent should fall by 2026; It is expected to arrive at SUS
Wegovy is used in conjunction with diet and exercises for people with BMI (body mass index) equal to or greater than or more, or greater than 27, but with other conditions, such as high blood pressure.
Both drugs are manufactured by the same pharmaceutical company, Novo Nordisk, which announced today the reduction of up to 20% in prices. The measure adopted by the company aims to combat forgery and trade in irregular products.
To the Facto News channelthe doctor said he was surprised by the price reduction.
We were surprised by this very positive news, a decrease of up to 20% in the cost of these medications. It is a very expressive reduction, as this family of medications is modern, effective. However, it has a large impediment for much of the population, which is the high cost. Remembering that more than half of the Brazilian population is overweight.
So all the measures that expand access-objectively to those who need, with medical follow-up-are very welcome. Lucas Costa, endocrinologist and nutrologist
What is the new price?
Novo Nordisk released values within the patient support program. In it, prices are lower than for those who are not registered. Check out the prices per box:
